Viewing StudyNCT00514371



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00514371
Status: COMPLETED
Last Update Posted: 2015-12-07
First Post: 2007-08-08

Brief Title: A Study of Tanespimycin KOS-953 in Patients With Relapsed-refractory Multiple Myeloma
Sponsor: Bristol-Myers Squibb
Organization: Bristol-Myers Squibb

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
Multiple Myeloma View
Heat Shock Protein 90 View
Hsp90 View
KOS-953 View
17-AAG View
bortezomib View
relapsed-refractory View
tanespimycin View